ARCHIVES

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

NIH Plans Conference On DCIS Diagnosis, Management

July 17, 2009

MRI, 3D Ultrasound Combination Can Guide Prostate Biopsies

December 28, 2012

ASCO Growth Changes, Prepare Society for ‘90s

June 8, 1990

In Brief: Construction Grant Application Deadline for 75-25% Funding Oct. 1; Fordham Quits

April 29, 1977

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005

In Brief: Maryland Wins Center Planning Grant; CRC Receives $5 Million To Endow Chair

December 10, 1999